FDA
-
-
-
-
-
-
-
Validated for Global Scale: DIAGNOS Passes Annual MDSAP Audit, Solidifying the Pathway to Approvals with Health Canada & FDA
-
-
-
-
-
-
-
DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit and receives its certification to move forward with FDA and Health Canada
-
-
-
-
-
-
-
DIAGNOS Gets the Green Light for the Use of its Diabetic Retinopathy Screening Technology in Quebec Hospitals
-
-
-
-
-
-
-
DIAGNOS and the CHUM are launching the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening
-
-
-
-
-
-
-
DIAGNOS will be Attending in San Francisco during the J.P. Morgan Health Care Conference Week to be held from January 10th to 13th, 2022
-
-
-
-
-
-
-
DIAGNOS Announces a Three-Year Contract Renewal with Optina Diagnostics Providing a Telemedicine Platform to Support their Early Detection of Alzheimer’s Disease Test
-
-
-
-
-
-
-
IRIS, a New Look Vision Group Inc. company, teams up with DIAGNOS in a multi-year agreement to implement Artificial Intelligence technology with support from the INVEST-AI Program
-
322,217 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

